Literature DB >> 27068090

TcI Isolates of Trypanosoma cruzi Exploit the Antioxidant Network for Enhanced Intracellular Survival in Macrophages and Virulence in Mice.

María Paola Zago1, Yashoda M Hosakote2, Sue-Jie Koo3, Monisha Dhiman4, María Dolores Piñeyro5,6, Adriana Parodi-Talice5,7, Miguel A Basombrio8, Carlos Robello5,6, Nisha J Garg9,4,10.   

Abstract

Trypanosoma cruzi species is categorized into six discrete typing units (TcI to TcVI) of which TcI is most abundantly noted in the sylvatic transmission cycle and considered the major cause of human disease. In our study, the TcI strains Colombiana (COL), SylvioX10/4 (SYL), and a cultured clone (TCC) exhibited different biological behavior in a murine model, ranging from high parasitemia and symptomatic cardiomyopathy (SYL), mild parasitemia and high tissue tropism (COL), to no pathogenicity (TCC). Proteomic profiling of the insect (epimastigote) and infective (trypomastigote) forms by two-dimensional gel electrophoresis/matrix-assisted laser desorption ionization-time of flight mass spectrometry, followed by functional annotation of the differential proteome data sets (≥2-fold change, P < 0.05), showed that several proteins involved in (i) cytoskeletal assembly and remodeling, essential for flagellar wave frequency and amplitude and forward motility of the parasite, and (ii) the parasite-specific antioxidant network were enhanced in COL and SYL (versus TCC) trypomastigotes. Western blotting confirmed the enhanced protein levels of cytosolic and mitochondrial tryparedoxin peroxidases and their substrate (tryparedoxin) and iron superoxide dismutase in COL and SYL (versus TCC) trypomastigotes. Further, COL and SYL (but not TCC) were resistant to exogenous treatment with stable oxidants (H2O2 and peroxynitrite [ONOO(-)]) and dampened the intracellular superoxide and nitric oxide response in macrophages, and thus these isolates escaped from macrophages. Our findings suggest that protein expression conducive to increase in motility and control of macrophage-derived free radicals provides survival and persistence benefits to TcI isolates of T. cruzi.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27068090      PMCID: PMC4907148          DOI: 10.1128/IAI.00193-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Peroxidases of trypanosomatids.

Authors:  Helena Castro; Ana M Tomás
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

Review 2.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

Review 3.  The paraflagellar rod of kinetoplastid parasites: from structure to components and function.

Authors:  Neil Portman; Keith Gull
Journal:  Int J Parasitol       Date:  2009-10-30       Impact factor: 3.981

4.  Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease.

Authors:  Alejandro G Schijman; Carlos A Vigliano; Rodolfo J Viotti; Juan M Burgos; Silvia Brandariz; Bruno E Lococo; Maria I Leze; Hector A Armenti; Mariano J Levin
Journal:  Am J Trop Med Hyg       Date:  2004-02       Impact factor: 2.345

5.  Global economic burden of Chagas disease: a computational simulation model.

Authors:  Bruce Y Lee; Kristina M Bacon; Maria Elena Bottazzi; Peter J Hotez
Journal:  Lancet Infect Dis       Date:  2013-02-08       Impact factor: 25.071

6.  Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source.

Authors:  M Postan; J A Dvorak; J P McDaniel
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

7.  Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AIDS.

Authors:  Juan M Burgos; Sandra Begher; Helder M Valadares Silva; Margarita Bisio; Tomas Duffy; Mariano J Levin; Andrea M Macedo; Alejandro G Schijman
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

8.  Chagas disease has now gone global.

Authors:  Herbert B Tanowitz; Louis M Weiss; Susan P Montgomery
Journal:  PLoS Negl Trop Dis       Date:  2011-04-26

9.  Chagas disease: "the new HIV/AIDS of the Americas".

Authors:  Peter J Hotez; Eric Dumonteil; Laila Woc-Colburn; Jose A Serpa; Sarah Bezek; Morven S Edwards; Camden J Hallmark; Laura W Musselwhite; Benjamin J Flink; Maria Elena Bottazzi
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

10.  Geographical distribution of Trypanosoma cruzi genotypes in Venezuela.

Authors:  Hernán J Carrasco; Maikell Segovia; Martin S Llewellyn; Antonio Morocoima; Servio Urdaneta-Morales; Cinda Martínez; Clara E Martínez; Carlos Garcia; Marlenes Rodríguez; Raul Espinosa; Belkisyolé A de Noya; Zoraida Díaz-Bello; Leidi Herrera; Sinead Fitzpatrick; Matthew Yeo; Michael A Miles; M Dora Feliciangeli
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26
View more
  13 in total

1.  Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.

Authors:  Magalí C Girard; Gonzalo R Acevedo; Lucía López; Micaela S Ossowski; María D Piñeyro; Juan P Grosso; Marisa Fernandez; Yolanda Hernández Vasquez; Carlos Robello; Karina A Gómez
Journal:  Immunology       Date:  2018-08-03       Impact factor: 7.397

2.  Kinetics, subcellular localization, and contribution to parasite virulence of a Trypanosoma cruzi hybrid type A heme peroxidase (TcAPx-CcP).

Authors:  Martín Hugo; Alejandra Martínez; Madia Trujillo; Damián Estrada; Mauricio Mastrogiovanni; Edlaine Linares; Ohara Augusto; Federico Issoglio; Ari Zeida; Darío A Estrín; Harry F G Heijnen; Lucía Piacenza; Rafael Radi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-08       Impact factor: 11.205

3.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.

Authors:  Sue-Jie Koo; Imran H Chowdhury; Bartosz Szczesny; Xianxiu Wan; Nisha J Garg
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 4.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

5.  Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.

Authors:  Andrea C Mesías; Natalia Sasoni; Diego G Arias; Cecilia Pérez Brandán; Oliver C F Orban; Conrad Kunick; Carlos Robello; Marcelo A Comini; Nisha J Garg; M Paola Zago
Journal:  Free Radic Biol Med       Date:  2018-10-23       Impact factor: 7.376

6.  The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.

Authors:  Lucía López; María Laura Chiribao; Magalí C Girard; Karina A Gómez; Paula Carasi; Marisa Fernandez; Yolanda Hernandez; Carlos Robello; Teresa Freire; María Dolores Piñeyro
Journal:  Immunology       Date:  2021-01-25       Impact factor: 7.397

7.  Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages.

Authors:  Sue-Jie Koo; Bartosz Szczesny; Xianxiu Wan; Nagireddy Putluri; Nisha Jain Garg
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

Review 8.  Reactive species and pathogen antioxidant networks during phagocytosis.

Authors:  Lucía Piacenza; Madia Trujillo; Rafael Radi
Journal:  J Exp Med       Date:  2019-02-21       Impact factor: 14.307

9.  Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress.

Authors:  Marcos Lopez; Herbert B Tanowitz; Nisha J Garg
Journal:  Curr Clin Microbiol Rep       Date:  2018-01-19

10.  Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.

Authors:  Luz P Quebrada Palacio; Mariela N González; Yolanda Hernandez-Vasquez; Alina E Perrone; Adriana Parodi-Talice; Jacqueline Bua; Miriam Postan
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.